Highly attenuated cytomegalovirus vaccine and production thereof

Details Highly attenuated cytomegalovirus vaccine and production thereof Highly attenuated cytomegalovirus vaccine and production thereof

1974-04-15

1976-05-25

Rosen, Sam

Drug, bio-affecting and body treating compositions

Lymphokine

195 13, A61K 3912, C12K 500

Patent

active

039594661

ABSTRACT:
A cytomegalovirus (CMV) vaccine, capable of inducing immunity in humans against cytomegalic inclusion disease (CID), without spread to contacts and with minimal excretion of the virus, is prepared by serially passaging virulent CMV in human diploid lung fibroblasts.

REFERENCES:
elek, et al., The Lancet, Jan. 5, 1974, pp. 1-5.
Chambers, et al., Applied Microbiology, Vol. 22, pp. 914-918, Nov. 1971.

Affiliated with

Also associated with

Rating

Highly attenuated cytomegalovirus vaccine and production thereof does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Highly attenuated cytomegalovirus vaccine and production thereof, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Highly attenuated cytomegalovirus vaccine and production thereof will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-906264